北大医药(000788.SZ)：前三季度净利润1.36亿元 同比增加4.31%

Core Viewpoint - North China Pharmaceutical (000788.SZ) reported a decline in operating revenue for the first three quarters of 2025, while net profit attributable to shareholders increased slightly [1] Financial Performance - The company achieved operating revenue of 1.231 billion yuan, a year-on-year decrease of 19.76% [1] - Net profit attributable to shareholders reached 136 million yuan, reflecting a year-on-year increase of 4.31% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 126 million yuan, showing a year-on-year decrease of 2.66% [1] - Basic earnings per share were reported at 0.2282 yuan [1]